Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche

Journal of Nuclear Medicine

Volumn 53, Issue 5, 2012, Pages 779-786

  Shokeen, Monica ^a   Zheleznyak, Alexander ^a   Wilson, Jessica M ^b   Jiang, Majiong ^b   Liu, Ruiwu ^c   Ferdani, Riccardo ^a   Lam, Kit S ^c   Schwarz, Julie K ^d   Anderson, Carolyn J ^a,b,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

64Cu; PET imaging; Premetastatic niche; Very late antigen 4

Indexed keywords

11 BIS(CARBOXYMETHYL) 1,4,8,11 TETRAAZABICYCLO[6.6.2]HEXADECANE CU 64; FIREFLY LUCIFERASE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BIOLUMINESCENCE; BONE MARROW; BONE MARROW CELL; BREAST TUMOR; CANCER THERAPY; CELL LINE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MELANOMA CELL; METASTASIS; MOLECULAR IMAGING; MORBIDITY; MORTALITY; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; NUDE MOUSE; PREMETASTATIC NICHE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCINTILLATION PROBE; SPLEEN; TUMOR CELL; TUMOR ENGRAFTMENT; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; BIOLOGICAL TRANSPORT; BONE MARROW CELLS; CELL LINE, TUMOR; HUMANS; INTEGRIN ALPHA4BETA1; LUMINESCENT MEASUREMENTS; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR IMAGING; NEOPLASM METASTASIS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; TUMOR MICROENVIRONMENT;

EID: 84860754668     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.100073     Document Type: Article

References (20)

1. Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med. 2007;13:535-541. (Pubitemid 350123764)
2. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta. 2009; 1796:293-308.
3. Fidler IJ, Nicolson GL. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. J Natl Cancer Inst. 1977;58:1867-1872. (Pubitemid 8123984)
4. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98-101.
5. Psaila B, Kaplan RN, Port ER, Lyden D. Priming the 'soil' for breast cancer metastasis: The pre-metastatic niche. Breast Dis. 2006-2007;26:65-74. (Pubitemid 46647415)
6. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438: 820-827. (Pubitemid 41753060)
7. Peng L, Liu R, Marik J, Wang X, Takada Y, Lam KS. Combinatorial chemistry identifies high-affinity peptidomimetics against a4b1 integrin for in vivo tumor imaging. Nat Chem Biol. 2006;2:381-389. (Pubitemid 43936939)
8. Denardo SJ, Liu R, Albrecht H, et al. 111In-LLP2A-DOTA polyethylene glycoltargeting {alpha}4{beta}1 integrin: Comparative pharmacokinetics for imaging and therapy of lymphoid malignancies. J Nucl Med. 2009;50:625-634.
9. McCarthy DW, Shefer RE, Klinkowstein RE, et al. Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol. 1997;24:35-43. (Pubitemid 27145595)
10. Sprague JE, Peng Y, Sun X, et al. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clin Cancer Res. 2004;10:8674-8682. (Pubitemid 40053436)
11. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: National Academy Press; 2011.
12. Qi J, Leahy RM. Resolution and noise properties of MAP reconstruction for fully 3-D PET. IEEE Trans Med Imaging. 2000;19:493-506.
13. Garmy-Susini B, Avraamides CJ, Schmid MC, et al. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res. 2010;70:3042-3051.
14. Osborn L, Vassallo C, Browning BG, et al. Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol. 1994;124:601-608. (Pubitemid 24064470)
15. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem. 1991;266:15075-15079. (Pubitemid 21907620)
16. Holzmann B, Gosslar U, Bittner M. Alpha 4 integrins and tumor metastasis. Curr Top Microbiol Immunol. 1998;231:125-141.
17. Vincent AM, Cawley JC, Burthem J. Integrin function in chronic lymphocytic leukemia. Blood. 1996;87:4780-4788. (Pubitemid 26162379)
18. Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the 'pre-metastatic niche': Within bone and beyond. Cancer Metastasis Rev. 2006;25:521-529. (Pubitemid 46071861)
19. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(1) stem cells from bone-marrow microenvironment. Nat Med. 2002;8:841-849.
20. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8:1369-1375. (Pubitemid 44835111)